No abstract

A modified mathematical model describing the human immunodeficiency virus (HIV) pathogenesis with cytotoxic T-lymphocytes (CTL) and infected cells in eclipse phase is presented and studied in this paper. The model under consideration also includes a saturated rate describing viral infection. First, the positivity and boundedness of solutions for nonnegative initial data are proved. Next, the global stability of the disease free steady state and the endemic steady states are established depending on the basic reproduction number R 0 and the CTL immune response reproduction number R CTL . Moreover, numerical simulations are performed in order to show the numerical stability for each steady state and to support our theoretical findings. Our model based findings suggest that system immunity represented by CTL may control viral replication and reduce the infection.

We model the transmission of the hepatitis B virus (HBV) by six differential equations that represent the reactions between HBV with DNA-containing capsids, the hepatocytes, the antibodies and the cytotoxic T-lymphocyte (CTL) cells. The intracellular delay and treatment are integrated into the model. The existence of the optimal control pair is supported and the characterization of this pair is given by the Pontryagin’s minimum principle. Note that one of them describes the effectiveness of medical treatment in restraining viral production, while the second stands for the success of drug treatment in blocking new infections. Using the finite difference approximation, the optimality system is derived and solved numerically. Finally, the numerical simulations are illustrated in order to determine the role of optimal treatment in preventing viral replication.

This paper investigates the dynamics of a COVID-19 stochastic model with isolation strategy. The white noise as well as the Lévy jump perturbations are incorporated in all compartments of the suggested model. First, the existence and uniqueness of a global positive solution are proven. Next, the stochastic dynamic properties of the stochastic solution around the deterministic model equilibria are investigated. Finally, the theoretical results are reinforced by some numerical simulations.

Summary This paper deals with an optimal control problem of a time‐delayed differential equation model that describes the interactions between hepatitis B virus (HBV) with HBV DNA‐containing capsids, liver cells (hepatocytes), and cytotoxic T‐lymphocyte immune response. Both the treatment and the intracellular delay are incorporated into the model. Furthermore, the existence of the optimal control pair is studied, and Pontryagin's minimum principle is used to characterize these 2 optimal controls. The first of them represents the efficiency of drug treatment in preventing new infections, whereas the second stands for the efficiency of drug treatment in inhibiting viral production. The optimality system is derived and solved numerically using the forward and backward difference approximation. Finally, numerical simulations are established to show the role of optimal therapy in controlling viral replication.

No abstract

This paper deals with an optimal control problem for an human immunodeficiency virus (HIV) infection model with cytotoxic T-lymphocytes (CTL) immune response and latently infected cells. The model under consideration describes the interaction between the uninfected cells, the latently infected cells, the productively infected cells, the free viruses and the CTL cells. The two treatments represent the efficiency of drug treatment in inhibiting viral production and preventing new infections. Existence of the optimal control pair is established and the Pontryagin's minimum principle is used to characterize these two optimal controls. The optimality system is derived and solved numerically using the forward and backward difference approximation. Finally, numerical simulations are performed in order to show the role of optimal therapy in controlling the infection severity.

No abstract